Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology

Inclusion Criteria: * Pediatric patients (up to 18 years old) diagnosed with growth hormone deficiency or disorders requiring growth hormone treatment. * Patients are currently undergoing growth hormone therapy. Includes both naive patients (those newly starting weekly treatment) and those already on treatment. * Families willing to use connected injector devices and participate in mobile-based psychometrics for the study duration. * Families are able and willing to regularly provide patient-reported outcomes (PROs) and adherence data through the Adhera®️ Caring Digital Program. * Participants willing to sign the informed consent form, confirming their understanding of the essential aspects of the study, including the potential risks, benefits and rights as participants. Exclusion Criteria: * Families/patients already enrolled in other study protocols, including the use of connected injector devices and participation in mobile-based psychometrics. * Patients with other significant medical conditions that could interfere with growth hormone treatment or the study's data collection processes. * Inability to understand or communicate in the language used for data collection and study participation, unless appropriate translation services are available and can be consistently utilized.